DETROIT, June 01, 2018 (GLOBE NEWSWIRE) -- On May 11, President Trump outlined a set of proposals in his blueprint to combat the increasing cost of prescription drugs for Americans, known as American Patients First. One proposed modification would end gag clauses: contracting terms designed to prevent pharmacists from discussing lower-cost drug alternatives with consumers.

MeridianRx is pleased to see attention drawn to this concerning practice. Sean Lancaster, MeridianRx’s senior vice president of operations, ensures that “MeridianRx is committed to transparency and affordability for our clients, and the move to prohibit these contract clauses is fully aligned with our company’s core values.”

MeridianRx’s dedication to true transparency means clients always know what they’re paying for, and provides patients with the information they need to make informed decisions about their care. Several states, including Arkansas, Connecticut, Georgia, Louisiana, Nevada, New York, North Dakota, and South Dakota, have already banned gag clauses.

“MeridianRx takes pride in our practice of never adopting these clauses in our contracts,” said Lancaster. “Putting patients first and keeping out-of-pocket costs low for our clients are fundamental to our overall mission.”

# # # 

About MeridianRx:

MeridianRx is the Pharmacy Benefit Manager (PBM) line of business within the Meridian family of companies. MeridianRx was established in 2007 to add flexibility and transparency in the PBM industry. MeridianRx has a pharmacy network of more than 67,000, serving 1.3 million members. To learn more about MeridianRx, please visit: www.meridianrx.com

Chelsea Davis
Meridian
313-324-3700 x 21292
chelsea.davis@mhplan.com